COPENHAGEN, Denmark, 19 November 2024 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announces that the Danish government has expressed its intention to make the Pilot Programme for prescription-based medicinal cannabis permanent. This proposal will be presented today by the Minister …
